DIABETES INSIPIDUS - PowerPoint PPT Presentation

About This Presentation
Title:

DIABETES INSIPIDUS

Description:

DI is a disorder resulting from deficiency of anti-diuretic hormone (ADH) or its ... It must be differentiated from other polyuric states such as primary polydipsia ... – PowerPoint PPT presentation

Number of Views:6678
Avg rating:3.0/5.0
Slides: 29
Provided by: drel151
Learn more at: http://www.bibalex.org
Category:

less

Transcript and Presenter's Notes

Title: DIABETES INSIPIDUS


1
DIABETES INSIPIDUS
  • Dr. Abdelaziz Elamin
  • MD, PhD, FRCPCH
  • Professor of Child Health
  • consultant pediatric endocrinologist
  • Sultan Qaboos University
  • Muscat, Oman.
  • azizmin_at_hotmail.com

2
DIABETES INSIPIDUS
  • DI is a disorder resulting from deficiency of
    anti-diuretic hormone (ADH) or its action and is
    characterized by the passage of copious amounts
    of dilute urine.
  • It must be differentiated from other polyuric
    states such as primary polydipsia osmotic
    duiresis. Central DI is due to failure of the
    pituitary gland to secrete adequate ADH.

3
DIABETES INSIPIDUS /2
  • Nephrogenic DI results when the renal tubules of
    the kidneys fail to respond to circulating ADH.
  • The resulting renal concentration defect leads to
    the loss of large volumes of dilute urine. This
    causes cellular and extracellular dehydration and
    hypernatremia.

4
THE POSTERIOR PITUITARY
  • Is composed of nerve fibers that have their cell
    bodies in the supraoptic paraventricular nuclei
    of the hypothalamus.
  • The neurosecretory cells in these nuclei
    synthesize Oxytocin Vasopressin which pass down
    the nerve fibres to be stored in released from
    the posterior pituitary.

5
REGULATION OF ADH SECRETION
  • ADH RELEASE IS STIMULATED BY
  • A PLASMA OSMOLALITY gt280 mOsm/l
  • A FALL IN PLASMA VOLUME
  • EMOTIONAL FACTORS STRESS
  • SLEEP
  • OTHER FACTORS

6
Other ADH Stimulants
  • CHOLINERGIC STIMULATION
  • a-ADRENERGIC STIMULATION
  • ANGIOTENSIN II
  • PROSTAGLANDIN E
  • OPIATES
  • NICOTINE
  • HISTAMINE
  • ETHER
  • PHENOBARBITONE

7
ADH SECRETION IS INHIBITED BY
  • ALCOHOL
  • OROPHARYNGEAL WATER REFLEX
  • b-DRENERGIC STIMULANTS
  • ATRIAL NATRIURETIC FACTOR (ANF)
  • PHENYTOIN

8
ADH
  • THE SUPRAOPTIC NUCLEUS (SON) IS RESPONSIBLE
    PREDOMINANTLY FOR THE SYNTHESIS OF VASOPRESSIN
    WHICH IS THE ADH.
  • THE CLOSE STRUCTURAL SIMILARITY OF VASOPRESSIN
    OXYTOCIN EXPLAINS THE OVERLAP OF THEIR BIOLOGICAL
    ACTIONS.

9
ADH (2)
  • ADH IS AN OCTAPEPTIDE LIKE OXYTOCIN.
  • THE ARGININE VASOPRESSIN IS ADH IN MAN AND OTHER
    MAMMALS APART FROM THE PIG THE HIPPOPOTAMUS
    WHERE LYSINE VASOPRESSIN IS THE ADH.

10
FUNCTION OF ADH
  • PRIMARY EFFECT OF ADH IS ON THE CELLS OF THE
    DISTAL TUBULES COLLECTING DUCTS OF THE KIDNEY
    PROMOTING REABSORPTION OF WATER.
  • THIS ACTION IS MEDIATED VIA V2-RECEPTORS THROUGH
    ACTIVATION OF cAMP AND FORMATION OF A SPECIFIC
    PROTEIN KNOWN AS AQUAPORIN.

11
Actions of ADH (2)
  • Beside water, AVP enhances reabsorption of urea
  • increasing tonicity of the renal medulla allowing
  • more water to be re-absorbed.
  • Acting on v1-receptors in peripheral vessels AVP
    causes vaso-constriction ?BP. Normally this is
    balanced by its inhibitory effect on sympathetic
    cardiac stimuli causing bradycardia

12
Actions of ADH (3)
  • DURING HYPOVOLEMIA HIGH PLASMA LEVELS OF AVP HELP
    MAINTAIN TISSUE PERFUSSION.
  • A LESSER SECONDARY EFFECT THAT IS MEDIATED VIA V2
    NON-RENAL RECEPTORS IS STIMULATION OF SYNTHESIS
    RELEASE OF FACTOR VIII VON WILLEBRAND FACTOR.

13
CAUSES OF CENTRAL DI
  • IDIOPATHIC (30 OF CASES)
  • SUPRASELLAR TUMOURS (30 OF CASES)
  • INFECTIONS (ENCEPHALITIS, TB, etc)
  • NON-INFECTIOUS GRANULOMA (SARCOID, HAND-SCHULLER
    CHRISTIAN DISEASE
  • TRAUMA OR SKULL SURGERY
  • LEUKAEMIA

14
CAUSES OF CENTRAL DI (2)
  • AUTOIMMUNE ASSOCIATED WITH THYROIDITIS
  • FAMILIAL 2 TYPES AD X-LINKED INHERITANCE
  • WOLFRAM SYNDROME (ALSO KNOWN AS DIDMOAD SYNDROME)
    CHARACTERIZED BY DI, DM, NERVE DEAFNESS AND OPTIC
    ATROPHY.

15
CAUSES OF NEPHROGENIC DI
  • PRIMARY FAMILIAL X-LINKED RECESSIVE THAT IS
    SEVERE IN BOYS MILD IN GIRLS
  • SECONDARY TO
  • CHRONIC PYELONEPHRITIS
  • HYPOKALEMIA
  • HYPERCALCEMIA
  • SICKLE CELL DISEASE
  • PROTEIN DEPRIVATION

16
CAUSES OF NEPHROGENIC DI/2
  • SECONDARY CAUSES continued
  • AMYLOIDOSIS
  • OTHER RENAL DISEASES (chronic renal failure,
    obstructive uropathy, polycystic disease)
  • SJOGREN SYNDROME
  • DRUGS (Lithium, Colchicine, Fluoride, Cidofovir,
    Demeclocycline, Methoyflurane)

17
CLINICAL FEATURES
  • POLYURIA, POLYDIPSIA THIRST
  • NOCTURIA OR NOCTURNAL ENURESIS
  • HYPERNATREMIC DEHYDRATION
  • ANOREXIA, CONSTIPATION FTT
  • HYPERTHERMIA LACK OF SWEATING
  • SYMPTOMS OF UNDERLYING CAUSE

18
COMPLICATIONS
  • HYPERNATREMIC DEHYDRATION ITS NEUROLOGICAL
    SEQUELEA
  • GROWTH RETARDATION
  • HYDRONEPHROSIS (DUE TO EXCESSIVE URINE OUTPUT)

19
DIAGNOSTIC WORKUP
  • CAREFUL HISTORY EXAMINATION
  • DOCUMENT PRESENCE OF POLYURIA (USUALLY 4-15
    L/24h)
  • PRACTICALLY SMILTANEOUS MEASUREMENT OF PLASMA
    URINE OSMOLALTY ESTABLISH THE DIAGNOSIS IN MOST
    CHILDREN WITH SEVERE DI MAKING A WATER
    DEPRIVATION TEST UNNECESSARY

20
DIAGNOSTIC WORKUP (2)
  • URINALYSIS MICROSCOPY TOGETHER WITH PLASMA
    ELECTROLYTES HELP EXCLUDE MOST OF THE CAUSES OF
    POLYURIA
  • IN A NORMAL WELL HYDRATED SUBJECT PLASMA
    OSMOLALITY IS lt290 mOsml/l AND URINE OSMOLALITY
    IS 300-450 mOsmol/l

21
DIAGNOSTIC WORKUP (3)
  • IN PATIENTS WITH DI FREE EXCESS TO WATER PLASMA
    OSMOLALITY IS gt295 mOsmol/l URINE OSOLALITY IS
    50-150 mOsmol/l.
  • IN PATIENTS WITH DI FREE EXCESS TO WATER PLASMA
    OSMOLALITY IS gt295 mOsmol/l URINE OSOLALITY IS
    50-150 mOsmol/l.

22
WATER DEPRIVATION TEST
  • WATER DEPRIVATION TEST IS NEEDED FOR PATIENTS
    WITH PARTIAL AVP DEFICIENCY ALSO TO
    DIFFERENTIATE DI FROM PRIMARY POLYDIPSIA WHICH IS
    VERY RARE IN CHILDREN

23
WATER DEPRIVATION TEST (2)
  • SHOULD BE DONE IN THE MORNING UNDER OBSERVATION
  • 8 HOURS FAST IS ENOUGH FOR CHILDREN
  • WEIGH THE CHILD HOURLY AND MEASURE PLASMA URINE
    OSMOLALITY EVERY 2 HOURS
  • IN NORMAL SUBJECTS PLASMA OSMOLALITY HARDLY RISES
    (lt 300) BUT THE URINE OUTPUT IS REDUCED ITS
    OSMOLALITY RISES (800-1200)

24
WATER DEPRIVATION TEST (3)
  • PATIENTS WITH PRIMARY POLYDIPSIA START WITH LOW
    NORMAL PLASMA OSMOLALITY (280) BUT URINE/PLASMA
    OSMOLALITY RATIO RISES TO gt2 AFTER DEHYDRATION.
  • IN PATIENTS WITH DI THE PLASMA BUT NOT THE URINE
    OSMOLALITY RISES AND U/P OSMOLALITY RATIO REMAINS
    lt 1.5

25
WATER DEPRIVATION TEST (4)
  • AT THE END OF THE TEST, ADH IS GIVEN (20 mg DDAVP
    INTRNASALLY OR 2 mg I.M.) AND FLUID INTAKE
    ALLOWED.
  • CONCENTRATION OF THE DILUTE URINE CONFIRMS
    CENTRAL DI AND FAILURE SUGGEST NEPHROGENIC CAUSES

26
TREATMENT
  • DESMOPRESSIN (DDAVP) A SYNTHETIC ANALOG IS
    SUPERIOR TO NATIVE AVP BECAUSE
  • IT HAS LONGER DURATION OF ACTION (8-10 h vs 2-3
    h)
  • MORE POTENT
  • ITS ANTIDIURETIC ACTIVITY IS 3000 TIMES GREATER
    THAN ITS PRESSOR ACTIVITY

27
DDAVP
  • USUALLY GIVEN INTRANASALLY BUT CAN BE GIVEN
    ORALLY OR I.M. FOR COMATOSE PATIENTS OR DURING
    SURGERY.
  • DDAVP CAN ALSO BE USED IN MILD HAEMOPHILIA OR VON
    WILLEBRAND DISEASE AND AS TREATMENT FOR NOCTURNAL
    ENURESIS IN CHILDREN

28
TREATMENT OF NEPHROGENIC DI
  • PROVISION OF ADEQUATE FLUIDS CALORIE
  • LOW SODIUM DIET
  • DIURETICS
  • HIGH DOSE OF DDAVP
  • CORRECTION OF UNDERLYING CAUSE
  • DRUGS (Indomethacin, Chlorprooramide, Clofibrate
    Carbamazepine)
Write a Comment
User Comments (0)
About PowerShow.com